284 related articles for article (PubMed ID: 2986016)
1. An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS.
Chang NT; Huang J; Ghrayeb J; McKinney S; Chanda PK; Chang TW; Putney S; Sarngadharan MG; Wong-Staal F; Gallo RC
Nature; 1985 May 9-15; 315(6015):151-4. PubMed ID: 2986016
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.
Ghrayeb J; Kato I; McKinney S; Huang JJ; Chanda PK; Ho DD; Sarangadharan MG; Chang TW; Chang NT
DNA; 1986 Apr; 5(2):93-9. PubMed ID: 3011373
[TBL] [Abstract][Full Text] [Related]
3. Expression in Escherichia coli of open reading frame gene segments of HTLV-III.
Chang NT; Chanda PK; Barone AD; McKinney S; Rhodes DP; Tam SH; Shearman CW; Huang J; Chang TW; Gallo RC
Science; 1985 Apr; 228(4695):93-6. PubMed ID: 2983429
[TBL] [Abstract][Full Text] [Related]
4. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG
J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
[TBL] [Abstract][Full Text] [Related]
6. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
Barone AD; Silva JJ; Ho DD; Gallo RC; Wong-Staal FF; Chang NT
J Immunol; 1986 Jul; 137(2):669-73. PubMed ID: 3013999
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
9. Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.
Steimer KS; Higgins KW; Powers MA; Stephans JC; Gyenes A; George-Nascimento C; Luciw PA; Barr PJ; Hallewell RA; Sanchez-Pescador R
J Virol; 1986 Apr; 58(1):9-16. PubMed ID: 2419593
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
[TBL] [Abstract][Full Text] [Related]
11. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
[TBL] [Abstract][Full Text] [Related]
12. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
[TBL] [Abstract][Full Text] [Related]
13. HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients.
Crowl R; Ganguly K; Gordon M; Conroy R; Schaber M; Kramer R; Shaw G; Wong-Staal F; Reddy EP
Cell; 1985 Jul; 41(3):979-86. PubMed ID: 2988795
[TBL] [Abstract][Full Text] [Related]
14. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
Allan JS; Coligan JE; Barin F; McLane MF; Sodroski JG; Rosen CA; Haseltine WA; Lee TH; Essex M
Science; 1985 May; 228(4703):1091-4. PubMed ID: 2986290
[TBL] [Abstract][Full Text] [Related]
15. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.
Allan JS; Coligan JE; Lee TH; McLane MF; Kanki PJ; Groopman JE; Essex M
Science; 1985 Nov; 230(4727):810-3. PubMed ID: 2997921
[TBL] [Abstract][Full Text] [Related]
16. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
17. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
Robert-Guroff M; Brown M; Gallo RC
Nature; 1985 Jul 4-10; 316(6023):72-4. PubMed ID: 2989707
[TBL] [Abstract][Full Text] [Related]
18. Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
Markham PD; Shaw GM; Salahuddin SZ; Hahn B; Sarngadharan MG; Gallo RC
Adv Exp Med Biol; 1985; 187():13-34. PubMed ID: 2994417
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
Weiss RA; Clapham PR; Cheingsong-Popov R; Dalgleish AG; Carne CA; Weller IV; Tedder RS
Nature; 1985 Jul 4-10; 316(6023):69-72. PubMed ID: 2989706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
